immun respons biopharmaceut concern engag
develop product treatment hiv infect
autoimmun diseas rheumatoid arthriti
immun product ltd. joint ventur immun
respons rhone-poulenc rorer conduct clinic
trial hiv therapeut vaccin human u.
trial schedul complet later year
primari object support product licens applic
1993 secur food drug administr approv
commer marketet hiv vaccin immuin
respons said
immun respons vaccin base scientif
approach first suggest dr. jona salk founder
immun respons develop salk polio vaccin dr
salk propos use whole inactiv aid virus
inocul peopl alreadi infect research
use genet engin synthet virus protein dr
salk chose use live virus kill gamma radiat
